Sign In

Login

Password

Forgot Password ? Sign Up

Digitoxin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Digitoxin" in German language version.

refsWebsite
Global rank German rank
10nih.gov
4th place
7th place
7doi.org
2nd place
3rd place
2google.de
2,106th place
139th place
1dguv.de
813th place
69th place
1europa.eu
68th place
29th place
1reach-clp-biozid-helpdesk.de
low place
979th place
1bfarm.de
low place
1,217th place
1abda.de
low place
low place

abda.de

bfarm.de

dguv.de

gestis.dguv.de

doi.org

  • J. Bauersachs, Lars S. Maier, Natalie ter Horst, Udo Bavendiek: Lieferengpass Digitoxin. In: . 2022, Band 17, Nummer 1, S. 39–42 doi:10.1007/s12181-022-00585-x.
  • H. Fuerstenwerth: On the differences between ouabain and digitalis glycosides. In: American journal of therapeutics. Band 21, Nummer 1, 2014 Jan-Feb, S. 35–42, doi:10.1097/MJT.0b013e318217a609, PMID 21642827.
  • Kurowski, V.; Iven, H.; Djonlagic, H.: Treatment of a patient with severe digitoxin intoxication by Fab fragments of anti-digitalis antibodies. In: Intensive Care Medicine. 18. Jahrgang, Nr. 7, 1992, S. 439–442, doi:10.1007/BF01694351, PMID 1469187 (englisch).
  • D. M. Roberts, N. A. Buckley: Antidotes for acute cardenolide (cardiac glycoside) poisoning. In: The Cochrane database of systematic reviews. Nummer 4, 2006, S. CD005490, doi:10.1002/14651858.CD005490.pub2, PMID 17054261.
  • L. Menger, E. Vacchelli, O. Kepp, A. Eggermont, E. Tartour, L. Zitvogel, G. Kroemer, L. Galluzzi: Trial watch: Cardiac glycosides and cancer therapy. In: Oncoimmunology. 2. Jahrgang, Nr. 2, 1. Februar 2013, S. e23082, doi:10.4161/onci.23082, PMID 23525565 (englisch).
  • HA Elbaz, TA Stueckle, W Tse, Y Rojanasakul, CZ Dinu: Digitoxin and its analogs as novel cancer therapeutics. In: Experimental Hematology & Oncology. 1. Jahrgang, Nr. 1, 5. April 2012, S. 4, doi:10.1186/2162-3619-1-4, PMID 23210930 (englisch).
  • JM Langenhan, NR Peters, IA Guzei, FM Hoffmann, JS Thorson: Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization. In: Proceedings of the National Academy of Sciences. 102. Jahrgang, Nr. 35, 30. August 2005, S. 12305–10, doi:10.1073/pnas.0503270102, PMID 16105948 (englisch).

europa.eu

echa.europa.eu

google.de

books.google.de

  • Withering, William: An Account of the Foxglove and Some of its Medical Uses: With Practical Remarks on Dropsy and other Diseases. 1785 (google.de).
  • Sneader, Walter: Drug discovery: A history. 2005, ISBN 978-0-471-89980-8, S. 107 (google.de).

nih.gov

ncbi.nlm.nih.gov

  • W. C. Diefenbach, J. K. Meneely Jr: Digitoxin; a critical review. In: The Yale Journal of Biology and Medicine. 21. Jahrgang, Nr. 5, 1949, S. 421–431, PMID 18127991, PMC 2598854 (freier Volltext) – (englisch).
  • G. G. Belz, K. Breithaupt-Grögler, U. Osowski: Treatment of congestive heart failure–current status of use of digitoxin. In: European journal of clinical investigation. Band 31 Suppl 2, 2001, S. 10–17, PMID 11525233.
  • H. Fuerstenwerth: On the differences between ouabain and digitalis glycosides. In: American journal of therapeutics. Band 21, Nummer 1, 2014 Jan-Feb, S. 35–42, doi:10.1097/MJT.0b013e318217a609, PMID 21642827.
  • Kurowski, V.; Iven, H.; Djonlagic, H.: Treatment of a patient with severe digitoxin intoxication by Fab fragments of anti-digitalis antibodies. In: Intensive Care Medicine. 18. Jahrgang, Nr. 7, 1992, S. 439–442, doi:10.1007/BF01694351, PMID 1469187 (englisch).
  • D. M. Roberts, N. A. Buckley: Antidotes for acute cardenolide (cardiac glycoside) poisoning. In: The Cochrane database of systematic reviews. Nummer 4, 2006, S. CD005490, doi:10.1002/14651858.CD005490.pub2, PMID 17054261.
  • L. Menger, E. Vacchelli, O. Kepp, A. Eggermont, E. Tartour, L. Zitvogel, G. Kroemer, L. Galluzzi: Trial watch: Cardiac glycosides and cancer therapy. In: Oncoimmunology. 2. Jahrgang, Nr. 2, 1. Februar 2013, S. e23082, doi:10.4161/onci.23082, PMID 23525565 (englisch).
  • HA Elbaz, TA Stueckle, W Tse, Y Rojanasakul, CZ Dinu: Digitoxin and its analogs as novel cancer therapeutics. In: Experimental Hematology & Oncology. 1. Jahrgang, Nr. 1, 5. April 2012, S. 4, doi:10.1186/2162-3619-1-4, PMID 23210930 (englisch).
  • JM Langenhan, NR Peters, IA Guzei, FM Hoffmann, JS Thorson: Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization. In: Proceedings of the National Academy of Sciences. 102. Jahrgang, Nr. 35, 30. August 2005, S. 12305–10, doi:10.1073/pnas.0503270102, PMID 16105948 (englisch).

chem.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

reach-clp-biozid-helpdesk.de